The Vanguard Group 13D and 13G filings for ClearPoint Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 2:35 pm Unchanged |
2024-09-30 | 13G | ClearPoint Neuro, Inc. CLPT |
The Vanguard Group | 1,242,993 4.500% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:28 am Sale |
2024-09-30 | 13G | ClearPoint Neuro, Inc. CLPT |
The Vanguard Group | 1,242,993 4.500% |
-65,701 (-5.02%) |
Filing |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | ClearPoint Neuro, Inc. CLPT |
The Vanguard Group | 1,308,694 5.320% |
1,308,694 (New Position) |
Filing |